Recent Finacing
Recent Raise
Hallux is an investigational-stage pharmaceutical company developing a biodegradable subungual micro-insert to deliver terbinafine hydrochloride directly to distal lateral subungual onychomycosis lesions, advancing through pilot and planned clinical studies.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor